GlassScriptPhysician profile
Daniel Krochmal
NPI 1578682993
$12,501.05
in general payments reported to CMS, 2019-2025
17 companies · $1,143 in 2025
The $1,143 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,105 · 2021: $2,479 · 2022: $3,736 · 2023: $1,107 · 2024: $931 · 2025: $1,143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,181.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $3,607.25 | 2022-2024 | Phasix Mesh, Arista Ah Flexitip |
| Tepha INC | $2,504.16 | 2019 | |
| Bard Peripheral Vascular, INC. | $1,732.32 | 2021 | |
| Motiva USA, LLC | $1,241.27 | 2024-2025 | |
| Sientra, INC. | $855.20 | 2019-2022 | |
| Tela Bio, INC. | $649.73 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $624.86 | 2019-2022 | |
| Abbvie INC. | $253.75 | 2022-2024 | |
| Rti Surgical, INC | $219.33 | 2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $210.19 | 2019-2021 | |
| Somavac Medical Solutions, INC. | $209.43 | 2025 | Somavac 100 Sustained Vacuum System |
| Becton, Dickinson and Company | $150.00 | 2025 | Phasix Mesh |
| Kerecis Limited | $143.43 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Galderma Laboratories, L.P. | $33.58 | 2019 | |
| Mentor Worldwide LLC | $32.13 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apollo Endosurgery US INC | $22.87 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Krochmal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.